Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$414.95
$412.89
$274.98
$613.16
$730.31M0.6231,602 shs36,896 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$32.83
+3.2%
$28.58
$23.10
$48.47
$781.03M1.16173,240 shs191,939 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$20.28
+7.3%
$17.73
$6.08
$43.51
$799.84M1.43545,732 shs644,255 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$11.00
+2.7%
$12.13
$5.27
$27.70
$679.36M0.37322,060 shs440,897 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%+5.05%+2.38%+22.77%-32.56%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+3.21%+8.49%+19.86%+25.16%-32.09%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
+7.30%+13.93%+14.25%+31.35%-51.49%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
+2.71%+5.77%-10.28%-21.60%-57.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
1.7214 of 5 stars
0.01.02.50.02.63.31.3
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
4.3003 of 5 stars
3.43.00.03.91.64.20.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.7654 of 5 stars
2.11.00.04.32.51.70.6
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
1.3138 of 5 stars
3.41.00.00.00.03.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$42.5029.45% Upside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.5511.17% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.83
Moderate Buy$19.5878.03% Upside

Current Analyst Ratings

Latest KIDS, ATRI, SILK, and TMCI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$19.00 ➝ $21.00
5/1/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$18.00 ➝ $20.00
4/10/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
3/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$50.00
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$169.33M4.31$19.61 per share21.16$138.02 per share3.01
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M5.25N/AN/A$16.14 per share2.03
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M4.52N/AN/A$3.88 per share5.23
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$187.12M3.63N/AN/A$2.24 per share4.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$11.0337.62N/A11.46%8.07%7.37%5/13/2024 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.92N/AN/AN/A-14.10%-5.03%-4.37%5/6/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.37N/AN/AN/A-29.02%-35.12%-20.45%8/6/2024 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$49.53M-$0.81N/AN/AN/A-26.47%-33.96%-19.99%5/7/2024 (Confirmed)

Latest KIDS, ATRI, SILK, and TMCI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.30N/A+$0.30N/AN/AN/A  
5/6/2024N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.42N/A+$0.42N/AN/AN/A  
4/30/2024Q1 2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.36+$0.04-$0.36$44.67 million$48.50 million    
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million
2/29/2024Q4 2023
Atrion Co. stock logo
ATRI
Atrion
N/A$3.65+$3.65$3.65N/A$43.58 million
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/27/2024Q4 2023
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.09-$0.10-$0.01-$0.10$60.56 million$62.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.802.12%+9.65%79.78%21 Years
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A

Latest KIDS, ATRI, SILK, and TMCI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
Atrion Co. stock logo
ATRI
Atrion
Quarterly$2.202.42%3/14/20243/15/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.09
2.57
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
5.44
2.90
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.38
4.40
3.76

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
24.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7121.76 million1.36 millionNot Optionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.79 million16.22 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.44 million36.80 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
51661.76 million46.67 millionOptionable

KIDS, ATRI, SILK, and TMCI Headlines

SourceHeadline
Treace Medical Concepts (TMCI) Scheduled to Post Earnings on TuesdayTreace Medical Concepts (TMCI) Scheduled to Post Earnings on Tuesday
americanbankingnews.com - April 30 at 4:34 AM
Treace Medical Concepts is Now Oversold (TMCI)Treace Medical Concepts is Now Oversold (TMCI)
nasdaq.com - April 27 at 9:20 AM
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA TourTreace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
globenewswire.com - April 24 at 7:00 AM
Treace to Present at Bank of America Health Care ConferenceTreace to Present at Bank of America Health Care Conference
finance.yahoo.com - April 17 at 9:36 AM
Treace Announces First Annual National Bunion DayTreace Announces First Annual National Bunion Day
globenewswire.com - April 16 at 7:00 AM
7 Stable Stocks for 50% Returns by Early 20257 Stable Stocks for 50% Returns by Early 2025
investorplace.com - April 15 at 9:45 AM
Treace Medical Concepts (NASDAQ:TMCI)  Shares Down 5.2% Treace Medical Concepts (NASDAQ:TMCI) Shares Down 5.2%
marketbeat.com - April 12 at 3:17 PM
Treace to Report First Quarter 2024 Financial ResultsTreace to Report First Quarter 2024 Financial Results
globenewswire.com - April 9 at 7:00 AM
Vanguard Group Inc. Has $54.93 Million Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Vanguard Group Inc. Has $54.93 Million Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
marketbeat.com - April 9 at 4:08 AM
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient MilestoneTreace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
globenewswire.com - March 25 at 7:00 AM
Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call TranscriptTreace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 1 at 2:00 PM
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price TargetsTreace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price Targets
finance.yahoo.com - March 1 at 9:00 AM
Treace Medical Concepts IncTreace Medical Concepts Inc
morningstar.com - March 1 at 12:54 AM
Treace Medical Concepts Full Year 2023 Earnings: EPS Misses ExpectationsTreace Medical Concepts Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 29 at 9:47 AM
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call TranscriptTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 9:47 AM
Buy Rating on Treace Medical Concepts: Promising Financial Outlook and Strategic Product Innovation Drive GrowthBuy Rating on Treace Medical Concepts: Promising Financial Outlook and Strategic Product Innovation Drive Growth
markets.businessinsider.com - February 28 at 6:24 PM
Treace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ...Treace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ...
finance.yahoo.com - February 27 at 8:36 PM
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue EstimatesTreace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - February 27 at 7:36 PM
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 GuidanceTreace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
globenewswire.com - February 27 at 4:05 PM
Globus Medical (GMED) Q4 Earnings and Revenues Beat EstimatesGlobus Medical (GMED) Q4 Earnings and Revenues Beat Estimates
msn.com - February 20 at 7:03 PM
Earnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to DeclineEarnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to Decline
finance.yahoo.com - February 20 at 1:26 PM
Earnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to DeclineEarnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to Decline
zacks.com - February 20 at 11:06 AM
TMCI Sep 2024 20.000 callTMCI Sep 2024 20.000 call
finance.yahoo.com - February 20 at 8:26 AM
TMCI Jun 2024 22.500 callTMCI Jun 2024 22.500 call
finance.yahoo.com - February 20 at 8:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Atrion logo

Atrion

NASDAQ:ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Treace Medical Concepts logo

Treace Medical Concepts

NASDAQ:TMCI
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.